We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Intelerad

Intelerad Medical Systems offers medical imaging PACS and cross-enterprise workflow solutions for imaging providers r... read more Featured Products: More products

Download Mobile App




Intelerad to Invest USD 75 Million in New AI Medical Imaging Offerings

By HospiMedica International staff writers
Posted on 22 Jun 2019
Intelerad Medical Systems (Montreal, Canada), a medical imaging software provider that specializes in diagnostic viewing, reporting and collaboration solutions, has announced a USD 75 million R&D investment towards extending its solutions portfolio.

Intelerad’s technology simplifies everyday tasks for radiologists and other healthcare professionals, enabling them to optimize efficiency and apply their expertise and energy toward more personalized services and follow-ups for every patient. More...
On a daily basis, Intelerad’s solutions enable radiologists to perform more than 200,000 diagnostic interpretations worldwide.

With an emphasis on cloud technology and artificial intelligence, Intelerad is focused on providing innovative Software as a Service (SaaS) solutions for healthcare. For example, the company’s cloud-based Clairvoyance productivity dashboard will incorporate machine learning technology to provide predictive insights to imaging departments, enabling real-time, data-driven decisions that contribute to higher quality, more timely care and better outcomes for patients. The company’s USD 75 million investment and ongoing focus on creating innovative, market-leading solutions for a global customer base are expected to fuel a two-fold increase in study volume.

“Medical imaging has undergone a significant transformation over the past 20 years, and Intelerad has been at the forefront of that evolution,” said Mr. Paul Lepage, President and CEO of Intelerad. “We are proud to support customers around the world in providing the highest standard of healthcare services. We will continue to make a difference in healthcare by delivering scalable, enterprise-wide medical imaging solutions for healthcare providers and their patients.”



Gold Member
12-Channel ECG
CM1200B
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Medical Adhesive
MED 5570U
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.